Home > Cashflow Statement > GLAND PHARMA
AD     Remove this Ad

GLAND PHARMA Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Investing Activities ₹1,705 Cr₹-1,757 Cr₹1,208 Cr₹-1,003 Cr₹-1,524 Cr

What is the latest Cash Flow from Investing Activities ratio of GLAND PHARMA ?

The latest Cash Flow from Investing Activities ratio of GLAND PHARMA is ₹1,705 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Investing Activities
Mar2025₹1,705 Cr
Mar2024₹-1,757 Cr
Mar2023₹1,208 Cr
Mar2022₹-1,003 Cr
Mar2021₹-1,524 Cr

How is Cash Flow from Investing Activities of GLAND PHARMA Trending?

Years Cash Flow from Investing Activities % Change
Mar2025 ₹1,705 Cr
Positive
Mar2024 ₹-1,757 Cr
Negative
Mar2023 ₹1,208 Cr
Positive
Mar2022 ₹-1,003 Cr
Negative
Mar2021 ₹-1,524 Cr -

Compare Cash Flow from Investing Activities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹30,415.5 Cr 0.5% 9.3% 20.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹423,195.0 Cr 3% 9.5% 3.1% Stock Analytics
DIVIS LABORATORIES ₹169,849.0 Cr 1.7% 3.1% 5.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,586.0 Cr 4.7% 11.7% 41.1% Stock Analytics
DR REDDYS LABORATORIES ₹109,054.0 Cr 2.1% 6.7% 11.6% Stock Analytics
CIPLA ₹108,703.0 Cr 1.3% 1.3% -9.4% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

0.5%

9.3%

20.1%

SENSEX

-1.7%

0.5%

8.3%


You may also like the below Video Courses